Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin vs Amoxicillin/Clavulanate in Acute Sinusitis
NCT00249210Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Aug 1993
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of levofloxacin in acute sinusitis (2 arms), sponsored by Johnson & Johnson. Primary endpoint: Clinical response rate. Started Aug 1993; status: completed.
02
Drugs
levofloxacin
03
Conditions
acute sinusitis
Beyond the preview
Go deeper on NCT00249210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00249210.